The closed-end fund (CEF) market showed mixed results last week, with fixed-income sectors generally outperforming and sector discounts returning to long-term averages. Activist investor Saba is pushing for management changes at BPRE due to weak performance, high fees, and a focus on raising distributions to attract investors. Nuveen Muni CEFs like NMCO remain highly valued, though NMCO's recent rights offering caused a 5% price drop with minimal expected NAV dilution unless discounts widen. FSCO stands out with strong NAV returns and a 28% discount, while CIK's low fees and recent sector gains make it increasingly attractive to investors.
Nyxoah announced preliminary Q3 2026 revenue of €9.2 million, up 19% sequentially, driven by a 29% increase in U.S. sales. The company submitted a PMA supplement to the FDA to expand its Genio device indication for patients with complete concentric c...
ASML Holding N.V. announced recent transactions under its ongoing share buyback program, repurchasing a total of 233,867 shares between October 12 and October 16, 2026. The shares were bought back at weighted average prices ranging from €1,444.83 to ...
The Phase 3 ALKIVIA trial demonstrated that efgartigimod significantly improves symptoms in patients with autoimmune myositis, including immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM). Patients showed meaningful clinical improve...
In 2025, Berkshire Hathaway, led by Greg Abel, received $479 million in dividends from its $1.3 billion investment in American Express. This highlights the value of holding strong dividend-paying stocks for steady income. Retail investors can apply s...
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
